Patrick Burnett - Net Worth and Insider Trading

Patrick Burnett Net Worth

The estimated net worth of Patrick Burnett is at least $3 Million dollars as of 2026-09-06. Patrick Burnett is the See Remarks of Arcutis Biotherapeutics Inc and owns about 117,592 shares of Arcutis Biotherapeutics Inc (ARQT) stock worth over $3 Million. Details can be seen in Patrick Burnett's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Patrick Burnett has not made any transactions after 2026-08-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Patrick Burnett

To

Are these stocks worth buying? — GuruFocus analysis for each holding

Patrick Burnett Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Patrick Burnett owns 2 companies in total, including Arcutis Biotherapeutics Inc (ARQT) , and Verrica Pharmaceuticals Inc (VRCA) .

Click here to see the complete history of Patrick Burnett’s form 4 insider trades.

Insider Ownership Summary of Patrick Burnett

Ticker Company Transaction Date Type of Owner
ARQT Arcutis Biotherapeutics Inc 2026-08-19 See Remarks
VRCA Verrica Pharmaceuticals Inc 2018-06-14 Chief Medical Officer

Patrick Burnett Latest Holdings Summary

Patrick Burnett currently owns a total of 1 stock. Patrick Burnett owns 117,592 shares of Arcutis Biotherapeutics Inc (ARQT) as of August 19, 2026, with a value of $3 Million.

Latest Holdings of Patrick Burnett

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ARQT Arcutis Biotherapeutics Inc 2026-08-19 117,592 23.89 2,809,273

Holding Weightings of Patrick Burnett


Patrick Burnett Form 4 Trading Tracker

According to the SEC Form 4 filings, Patrick Burnett has made a total of 34 transactions in Arcutis Biotherapeutics Inc (ARQT) over the past 5 years, including 0 buys and 34 sells. The most-recent trade in Arcutis Biotherapeutics Inc is the sale of 1,697 shares on August 19, 2026, which brought Patrick Burnett around $45,819.

Insider Trading History of Patrick Burnett

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Patrick Burnett Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Get the full picture on these stocks
See GF Score, valuation, financials, and warning signs for every stock Patrick Burnett owns.
View ARQT Analysis

Patrick Burnett Ownership Network

Ownership Network List of Patrick Burnett

No Data

Ownership Network Relation of Patrick Burnett

Insider Network Chart


Patrick Burnett Owned Company Details

What does Arcutis Biotherapeutics Inc do?

Who are the key executives at Arcutis Biotherapeutics Inc?

Patrick Burnett is the See Remarks of Arcutis Biotherapeutics Inc. Other key executives at Arcutis Biotherapeutics Inc include director & President and CEO Todd Franklin Watanabe , SVP and General Counsel Masaru Matsuda , and SVP Chief Financial Officer Latha Vairavan .

Arcutis Biotherapeutics Inc (ARQT) Insider Trades Summary

Over the past 18 months, Patrick Burnett made 19 insider transaction in Arcutis Biotherapeutics Inc (ARQT) with a net sale of 185,015. Other recent insider transactions involving Arcutis Biotherapeutics Inc (ARQT) include a net sale of 150,682 shares made by Howard G. Welgus , a net sale of 249,271 shares made by Todd Franklin Watanabe , and a net sale of 122,887 shares made by Masaru Matsuda .

In summary, during the past 3 months, insiders sold 81,666 shares of Arcutis Biotherapeutics Inc (ARQT) in total and bought 0 shares, with a net sale of 81,666 shares. During the past 18 months, 936,204 shares of Arcutis Biotherapeutics Inc (ARQT) were sold and 27,448 shares were bought by its insiders, resulting in a net sale of 908,756 shares.

Arcutis Biotherapeutics Inc (ARQT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Arcutis Biotherapeutics Inc Insider Transactions

No Available Data

Patrick Burnett Mailing Address

Above is the net worth, insider trading, and ownership report for Patrick Burnett. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Patrick Burnett's mailing address is: West Chester Pa 19380.